THE BRIDGE HATTR AMYLOIDOSIS

Serial Number 87795814
Registration 5665054
702

Registration Progress

Application Filed
Feb 13, 2018
Under Examination
Approved for Publication
Nov 13, 2018
Published for Opposition
Nov 13, 2018
Registered
Jan 29, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-01-29)
Due: Jan 29, 2025 Overdue

Basic Information

Serial Number
87795814
Registration Number
5665054
Filing Date
February 13, 2018
Registration Date
January 29, 2019
Published for Opposition
November 13, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Sep 6, 2024
Registration
Registered
Classes
044

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
675 West Kendall Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Renewal Deadline
1301 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-01-29)
Due Date
January 29, 2029
Grace Period Ends
July 29, 2029

Application History

30 events
Date Code Type Description
Sep 6, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 6, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 6, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 20, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Jan 29, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 30, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 30, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 23, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 23, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 23, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 23, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 29, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER
Nov 13, 2018 PUBO A PUBLISHED FOR OPPOSITION
Nov 13, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 8, 2018 ALIE A ASSIGNED TO LIE
Sep 21, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2018 CNRT R NON-FINAL ACTION WRITTEN
Apr 7, 2018 GNRT F NON-FINAL ACTION E-MAILED
Mar 29, 2018 DOCK D ASSIGNED TO EXAMINER
Feb 22, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 21, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Providing medical information about hereditary ATTR (hATTR) amyloidosis
First Use Anywhere: Jun 30, 2017
First Use in Commerce: Jun 30, 2017

Additional Information

Design Mark
The mark consists of the word "THE" located to the left of the design of a bridge, both located over the word "BRIDGE". Under the word "BRIDGE" is a horizontal line, and under that are the words "HATTR AMYLOIDOSIS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HATTR AMYLOIDOSIS"